Jung Won Kim

Increased Systemic Exposure of Fimasartan, an Angiotensin II Receptor Antagonist, by Ketoconazole and Rifampicin

Min Goo Lee, Joo-Youn Cho, K. Yu, 2013, Journal of clinical pharmacology.

Tolerability and pharmacokinetics of lobeglitazone (CKD-501), a peroxisome proliferator-activated receptor-γ agonist: a single- and multiple-dose, double-blind, randomized control study in healthy male Korean subjects.

Joo-Youn Cho, K. Yu, Jung-Ryul Kim, 2011, Clinical therapeutics.